Pharmaceutical Law & Industry Report® Index-Summary

NAMENDA

– Alzheimer's drug infringement by generic settlement (D. Del.), 7
– Dementia drug, generic patent settlement (D. Del.), 978

NANOTECHNOLOGY

– Safety

See LEGISLATION, FEDERAL, S 2942

NAPROXCINOD

– Arthritis drug, FDA panel rejection, 658

NAROPIN

– Anesthetic infringement ruling vacated (Fed. Cir.), 1463

NATAZIA

– Contraceptive approval, 632

NATIONAL INSTITUTES OF HEALTH (NIH)

– Collaboration with FDA, 245
– Comparative effectiveness research grants, 359
– FY2011 budget proposal, 165

NEOPROFEN

– Anti-inflammatory drug recall, 1034

NEURONTIN

– Causation, expert testimony (D. Mass.), 1146
– Epilepsy drug and suicide, widow's suit (M.D. Tenn.), 322; expert testimony, 627; settlement, 682
– Generic approvals, 760
– Off-label promotion, jury verdict (D. Mass.), 416; Cal. sales, 1426

NEUTROVAL

– Neutropenia drug, biologics license application, 170

NEW YORK

– Copay limits, 1284
– Financial relationships between providers and drug and device makers, 169
– Formulary specialty tiers, 755; banned, 1284
– Medicaid

– – AWP suit dismissal (D. Mass.), 1465
– – OTC coverage, 1284

NEXIUM

– Deceptive marketing suit (D. Del.), 645
– Heartburn drug

– – Dr. Reddy's generic challenge (D.N.J.), 1431
– – Ivax generic patent settlement (D.N.J.), 59

– Response letter, 729

NIGERIA

– Trovan clinical trial injuries (U.S., brief filed), 719; (rev den), 852; limited discovery (S.D.N.Y.), 1345

NIMODIPINE

– Subarachnoid hemorrhage drug, FDA warning, 1029

NORFLOXACIN

– Antibiotic, Canadian generic delay (Fed. Ct.), 502

NORTH CAROLINA

– Medicaid preferred drug list, 363

NORTH DAKOTA

– Canadian drug imports, pilot program with Mont., 525

NORVASC

– Canada, antihypertensive patent invalid, 1065

NORVIR

– Invirase-Norvir and abnormal heart rhythms, 253
– Protease inhibitor, predatory pricing suit (N.D. Cal.), 781; mandamus denied (9th Cir.), 1246

NSAID

– Nonsteroidal anti-inflammatory drug design defect (D.N.H.), 986

NUVIGIL

– Apotex generic challenge (D.N.J.), 1107
– Watson generic of sleep disorder drug, challenge (D. Del.), 36